Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Sanofi-Aventis S.A. ADR (NQ: SNY ) 57.59 -0.06 (-0.10%) Streaming Delayed Price Updated: 2:52 PM EDT, Sep 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Sanofi-Aventis S.A. ADR < Previous 1 2 3 4 5 6 7 8 9 ... 30 31 Next > VeeCon 2024 Speakers Announced: X CEO Linda Yaccarino, Content Creator Khaby Lame, Gary Vee Among Special Guests To Appear At Festival That Combines Business, Pop Culture, Web3 May 29, 2024 For the third straight year, serial entrepreneur and VeeFriends founder Gary Vaynerchuk (aka Gary Vee) will host an annual conference that combines elements of business, pop culture Via Benzinga Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields May 28, 2024 Via Benzinga Zantac Verdict: Jury Finds No Link To Colon Cancer In Initial Trial, GSK And Boehringer Prevail In First Zantac Cancer Lawsuit May 24, 2024 Chicago jury rejects woman's claim that Zantac caused her colon cancer. First of thousands of similar lawsuits, companies deny scientific evidence. Via Benzinga Topics Lawsuit Exposures Financial Legal Why Vaccine Stocks Rallied This Week May 24, 2024 A bird flu outbreak could spur demand for vaccines from these key players, but is it likely? Via The Motley Fool Why Novavax Stock More Than Doubled Today May 10, 2024 A cloud of doubt hanging over the company just gave way to some sunshine. Via The Motley Fool The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom May 23, 2024 These are the biotech stocks to buy for a massive rally in the coming quarters on the back of positive clinical progress. Via InvestorPlace First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential May 22, 2024 Sanofi reveals Phase 2 results for rilzabrutinib in moderate-to-severe asthma. High and low doses showed a reduction in asthma control loss events and symptom improvements. Via Benzinga Hawaii Court Rules Against Bristol Myers, Sanofi In Blood Clot Drug Case, Increases Liability To $916M May 22, 2024 A Hawaii judge has ordered Bristol Myers Squibb and Sanofi to pay $916 million for not warning non-white patients about the health risks of their blood thinner Plavix. The ruling follows a previous... Via Benzinga 3 Biotech Stocks to Buy Now: May 2024 May 22, 2024 As the biotech industry continues to rise in market prominence, investors should start considering what the best biotech stocks to buy are. Via InvestorPlace 3 Things You Need to Know If You Buy Novavax Today May 22, 2024 The vaccine maker's recovery story is looking brighter. Via The Motley Fool ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development May 21, 2024 Sanofi collaborates with OpenAI and Formation Bio to enhance drug development. The partnership leverages proprietary data, advanced AI models, and engineering expertise to accelerate the biopharma... Via Benzinga Topics Artificial Intelligence Exposures Artificial Intelligence Roaring Kitty’s Rally Cry: 3 Meme Stocks to Pounce On Now May 20, 2024 Jump into action with NVAX, HOOD and WKHS as top meme stocks to buy, offering the chance to capitalize on short squeezes and momentum. Via InvestorPlace This Stock Just More Than Doubled in 1 Day: Is It a Buy? May 19, 2024 The biotech still hasn't lost momentum. Via The Motley Fool Could Novavax Become the Next Moderna? May 17, 2024 Sanofi believes in Novavax's vaccine strengths... Via The Motley Fool Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game May 16, 2024 On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a total of nearly $1 billion in their operations in France,... Via Benzinga Takeda's Dengue Vaccine Gets WHO Approval, Eligible for UN Procurement May 15, 2024 Takeda's dengue vaccine, Qdenga, gains WHO prequalification, enabling UN agency procurement. Approved in multiple countries, Qdenga is recommended for children 6-16 in high dengue areas. Via Benzinga Is DoubleVerify’s 39% Haircut a Buying Opportunity? May 15, 2024 Digital advertising verification and measurement solutions provider DoubleVerify Holdings Inc. (NYSE: DV) shares took a 39% plunge on its Q1 2024 earnings Via MarketBeat Topics Artificial Intelligence Fraud Malware Exposures Artificial Intelligence Information Security Legal 3 Stocks Under $2 That Can Trade in Double Digits by 2025 May 15, 2024 These stocks under $2 are likely to surge higher as they represent companies with impending growth catalysts. Via InvestorPlace Novavax Stock Just Tripled. Is It Too Late to Buy? May 15, 2024 Novavax shares have soared and plummeted in recent years. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session May 14, 2024 Via Benzinga 3 Cheap Biotech Stocks to Buy Now: May 2024 May 14, 2024 Many of these cheap biotech stocks are on their way to achieving FDA approval for their drugs to enter the market. Via InvestorPlace Exposures Product Safety 3 Meme Stocks That Are Likely to Crater in 2024 May 14, 2024 These are the meme stocks to avoid as they represent fundamentally weak companies with a sluggish growth outlook. Via InvestorPlace Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector May 13, 2024 Pfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D capabilities and job creation. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday May 13, 2024 It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning! Via InvestorPlace Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2024 May 13, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy May 13, 2024 From Fulcrum Therapeutics, Inc. Via GlobeNewswire Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) May 13, 2024 From Regeneron Pharmaceuticals, Inc. Via GlobeNewswire NVAX Stock Alert: Novavax Just Hit a New 52-Week High May 10, 2024 Novavax stock is heading higher on Friday as NVAX investors celebrate it reaching a new 52-week high following a deal with Sanofi. Via InvestorPlace Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? May 10, 2024 A worse-than-expected University of Michigan’s May consumer report halted stock gains on Friday, sparking worries about a potential decline in consumer health amid perceived rising price pressures. Via Benzinga Topics Economy Exposures Interest Rates Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal May 10, 2024 NVAX stock is rising higher after the biotechnology company announced that it had signed a licensing deal with Sanofi. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 ... 30 31 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.